These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18595145)

  • 21. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
    Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
    Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
    Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].
    Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.
    Li H; Fang L; Xiao X; Shen L
    Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
    Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis.
    Wu Y; Meng L; Wang H; Xu Q; Wang S; Wu S; Xi L; Zhao Y; Zhou J; Xu G; Lu Y; Ma D
    Oncol Rep; 2006 Sep; 16(3):625-9. PubMed ID: 16865265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interaction between abnormal expression of fragile histidine triad and methyl-CpG-binding protein 2 on cervical cancerization].
    Yang Q; Li Y; Wang L; Song ZC; Feng MJ; Ding L; Wang JT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):689-693. PubMed ID: 29860820
    [No Abstract]   [Full Text] [Related]  

  • 32. [The inhibition of fragile histidine triad gene on the proliferation and tumorigenicity of mucoepidermoid carcinoma cells].
    Liu F; Wu JZ; Li F; Li Y; Li J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Jun; 26(3):252-5. PubMed ID: 18705504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of the FHIT gene favors bladder cancer development.
    Vecchione A; Sevignani C; Giarnieri E; Zanesi N; Ishii H; Cesari R; Fong LY; Gomella LG; Croce CM; Baffa R
    Clin Cancer Res; 2004 Nov; 10(22):7607-12. PubMed ID: 15569992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest.
    Fan J; Lou B; Chen W; Zhang J; Lin S; Lv FF; Chen Y
    Tumour Biol; 2014 Nov; 35(11):11523-32. PubMed ID: 25129440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FHIT: doubts are clear now.
    Wali A
    ScientificWorldJournal; 2010 Jun; 10():1142-51. PubMed ID: 20563537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.
    Nam CW; Shin JW; Park NH
    World J Gastroenterol; 2008 Jun; 14(22):3526-33. PubMed ID: 18567082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells.
    Ji WD; Chen JK; Lu JC; Wu ZL; Yi F; Feng SM
    Biomed Environ Sci; 2006 Aug; 19(4):277-84. PubMed ID: 17044645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35.
    Pichiorri F; Trapasso F; Palumbo T; Aqeilan RI; Drusco A; Blaser BW; Iliopoulos D; Caligiuri MA; Huebner K; Croce CM
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3494-501. PubMed ID: 16740775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo.
    Xiong Z; Lü MH; Fan YH; Cao YL; Hu CJ; Wu YY; Wang SM; Luo G; Fang DC; Li C; Yang SM
    Int J Oncol; 2012 May; 40(5):1601-9. PubMed ID: 22267022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.